Choline phospholipid metabolism in cancer: Consequences for molecular pharmaceutical interventions

Research output: Contribution to journalReview article


Over the past decade, our program has focused on understanding the role of the physiological environment, tumor vasculature, and metabolism in several of the aggressive phenotypic traits of cancer, such as invasion and metastasis. These studies have been performed primarily with magnetic resonance (MR) imaging (MRI) and spectroscopy (MRS) on human breast and prostate cancer models. During the course of these studies, we observed specific changes in choline phospholipid metabolism associated with a more aggressive phenotype. Molecular or pharmacologic interventions that reduced this aggressiveness were also consistent with a reversal of these alterations. In this contextual review, we have outlined the insight we have gained from these studies and have discussed some of the enzymes and pathways that may present novel targets for pharmaceutical interventions in cancer.

Original languageEnglish (US)
Pages (from-to)496-506
Number of pages11
JournalMolecular Pharmaceutics
Issue number5
StatePublished - Sep 1 2006


  • Cancer
  • Choline phospholipid metabolism
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint Dive into the research topics of 'Choline phospholipid metabolism in cancer: Consequences for molecular pharmaceutical interventions'. Together they form a unique fingerprint.

  • Cite this